| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.539 | 44.769 | 125.047 | 348.142 | 424.152 | 372.289 | 493.439 | 584.893 | 749.808 | 959.626 |
| Total Income - EUR | 4.539 | 44.769 | 125.083 | 348.201 | 424.159 | 375.171 | 493.478 | 592.836 | 765.006 | 961.785 |
| Total Expenses - EUR | 4.232 | 15.807 | 89.359 | 215.329 | 289.618 | 259.174 | 299.286 | 436.382 | 584.743 | 706.812 |
| Gross Profit/Loss - EUR | 306 | 28.962 | 35.724 | 132.872 | 134.540 | 115.996 | 194.191 | 156.454 | 180.263 | 254.973 |
| Net Profit/Loss - EUR | 174 | 27.619 | 34.052 | 129.390 | 130.299 | 112.739 | 189.848 | 151.477 | 162.272 | 219.846 |
| Employees | 0 | 0 | 3 | 4 | 5 | 5 | 4 | 5 | 6 | 7 |
Check the financial reports for the company - Ocularcare Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 29.962 | 67.885 | 131.267 | 513.215 | 519.663 | 480.377 | 468.573 | 1.561.309 | 1.714.566 | 1.883.290 |
| Current Assets | 3.862 | 2.485 | 5.179 | 46.319 | 114.576 | 147.186 | 127.861 | 128.057 | 102.166 | 82.381 |
| Inventories | 1.462 | 244 | 236 | 477 | 228 | 223 | 219 | 1.108 | 1.090 | 333 |
| Receivables | 0 | 19 | 167 | 7.391 | 11.717 | 14.823 | 23.118 | 18.375 | 29.953 | 31.282 |
| Cash | 2.400 | 2.221 | 4.776 | 38.451 | 102.632 | 132.139 | 104.525 | 108.574 | 71.123 | 50.765 |
| Shareholders Funds | 219 | 27.836 | 61.422 | 189.685 | 316.310 | 359.478 | 522.203 | 675.300 | 835.525 | 1.050.701 |
| Social Capital | 45 | 45 | 48 | 47 | 46 | 45 | 44 | 45 | 44 | 44 |
| Debts | 33.605 | 42.533 | 75.024 | 369.850 | 317.966 | 268.602 | 75.087 | 1.016.689 | 984.000 | 915.421 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ocularcare Srl